CLSK

Value Q1, 25Q2, 26 TTM Total revenue 223 K-3.99 M -2.76 M Gross profit -95.4 M-85.68 M -367.46 M Operating expenses 402.11 M400.4 M 790.42 M Selling/general/admin expenses 15.44 M16.11 M 62.38 M Research & development —— — Operating income -316.55 M-345.68 M -415.24 M Non-Operating Income, Total —— — Interest expense, net of interest capitalized 3.93 M1.95 M 14.39 M Non-Operating Income, excl. Interest Expenses —— — Unusual income/expense —— — Pretax income -378.71 M-378.34 M -107.32 M Equity in earnings —— — Taxes 31.41 M9.89 M 68.16 M Non-controlling/minority interest —— — After tax other income/expense —— — Net income before discontinued operations -378.71 M-378.34 M -500.59 M Discontinued operations —— — Net income -378.71 M-378.34 M -500.59 M Dilution adjustment 00 0 Preferred dividends 030 M 36 M Diluted net income available to common stockholders -378.71 M-408.34 M -536.59 M Basic earnings per share (Basic EPS) -1.35-1.52 -1.98 Diluted earnings per share (Diluted EPS) -1.35-1.52 -2.1 Average basic shares outstanding 281.47 M267.83 M — Diluted shares outstanding 281.47 M267.83 M — EBITDA -391.2 M-370.2 M -732.48 M EBIT -497.51 M-486.08 M -1.16 B Cost of revenue 95.62 M81.69 M 364.7 M Other cost of goods sold —— — Depreciation & amortization (cash flow) 106.31 M115.88 M 425.4 M